QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
0 hedge funds and large institutions have $0 invested in QIAGEN NV in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $3.11M → $0 (-$3.11M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Fund Management (CFM)
Paris,
France
|
-$3.11M |
QGENF Hedge Fund Activity: Q2 2019 in Review
0 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q2 2019, worth a combined $0 — down 100% from $3.11M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of QGENF and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Capital Fund Management (CFM), exiting entirely with an estimated $3.11M sold.
- 0 institutional investors held QIAGEN NV (QGENF) as of Q2 2019, down from 1 in Q1 2019.
- Funds reported $0 of QIAGEN NV stock for Q2 2019, down 100% quarter-over-quarter.
- 0 funds opened new QIAGEN NV positions in Q2 2019 and 1 closed out, a net change of -1 holder.
- The largest QIAGEN NV seller in Q2 2019 was Capital Fund Management (CFM), an estimated $3.11M sold.
Based on aggregated 13F filings for Q2 2019.